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Axonal excitability and conduction alterations caused by levobupivacaine in rat
In this study, eff ects of the long-acting amide-type local anesthetic levobupivacaine on axonal conduction and excitability parameters of the rat sciatic nerve were thoroughly examined both in vitro and in vivo. In order to deduce its eff ects on isolated nerve conduction, compound nerve action potential (CNAP) recordings were performed using the suction method over sciatic nerves of Wistar rats before and aft er administration of 0.05 % (1.7 mmol L -1 ) levobupivacaine. Levobupivacaine caused complete CNAP area and amplitude depression by blocking conduction in a timedependent manner. To assess the infl uence of levobupivacaine on in vivo excitability properties, threshold-tracking (TT) protocols were performed at sciatic nerves of rats injected with perineural 0.05 % (1.7 mmol L -1 ) levobupivacaine or vehicle alone. Charge-duration TT results revealed that levobupivacaine increases the rheobase and decreases the strength-duration time constant, suggesting interference of the anesthetic with the opening of Na + channels. Twenty and 40 % threshold electrotonus curves were found for both groups to follow the same paths, suggesting no signifi cant eff ect of levobupivacaine on K + channels for either the fastest or relatively slow conducting fi bers. Current-threshold relationship results revealed no signifi cant eff ect on axonal rectifying channels. However, according to the results of the recovery cycle protocol yielding the patt ern of excitability changes following the impulse, potential deviation was found in the recovery characteristics of Na + channels from the absolute refractory period. Consequently, conduction blockage caused by levobupivacaine may not be due to the passive (capacitive) properties of axon or the conductance of potassium channels but to the decrease in sodium channel conductance.
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Levobupivacaine is a long-acting amide-type local anesthetic that interferes with voltage-gatedion channels. The anesthetic and/or analgesic eff ects of levobupivacaine have been shown to be largely similar, however less toxic compared to bupivacaine at the same dose, in many comparative studies, including those of epidural, peripheral nerve blockage, local infi ltration and peribulbar administration (1) . The sensory block due to levobupivacaine is longer than that of bupivacaine when used on peripheral nerves, not imposing any cardiovascular or CNS toxicity because of its enantio selectivity. On the contrary, bupivacaine has been shown to produce aQTc interval prolongation on ECG and overall depression of EEG signals. Levobupivacaine is a local anesthetic widely known for its blocking eff ect on Na + channels, but in recent studies it has been shown to aff ect K + , Ca
2+
, transient receptor potential vanilloid 1 (TRPV1) channels and N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-izoxazolepropionic acid (AMPA), and GTP-binding protein coupling receptors (2) . Combined eff ects of levobupivacaine on these ion channels and receptors could result in complicated changes in peripheral nerve conduction and excitability.
Since the ingenious works of Gasser and co-workers in the late 1930s (3), methods depending on the compound nerve action potential (CNAP) recording have been used as a useful means for the evaluation of nerves both for the purpose of research and clinical diagnosis. To get detailed information on the individual activity of nerve fi ber groups, CNAP recording from isolated nerves is still considered as the primary method of choice (4) . However, thanks to the threshold tracking (TT) method developed by Bostock et al. (5) in the last decade, more parameters about nerve excitability could be acquired reliably. Since the excitability of an axon could be defi ned as the current required to yield a specifi c level of response, excitability can be indirectly measured over the applied amount of electrical current. Depolarization of an axon increases its excitability and there by decreases the strength of threshold current needed to cause excitation; hence, a weaker current would be needed to produce the same magnitude of response, and vice versa. On the other hand, hyperpolarization of the axon increases the amount of current needed to produce a comparable response. In this method, a given response amplitude of the target compound muscle action potential (CMAP) or compound nerve action potential (CNAP), consisting of the sum of individual activities of muscle or nerve fi bers, is preset. The threshold current strength is then automatically adjusted to elicit this constant target response. These automatically driven patt erns of "percent change threshold" are taken to be an accurate representation of axonal excitability under the point of stimulation (6) .
A myelinated axon has ion channels, pumps and exchangers responsible for determining axonal excitability. In the node of Ranvier, transient Na + channels (Na t ) are densely clustered together with persistent Na + channels (Na p ) and slow K + channels (K s ), which as a whole contribute to the excitability and resting membrane potential. In addition to K s , the internodal region of the axon includes fast K + channels (K f ) scatt ered densely, acting to limit re-excitation of the node just aft er an action potential, and hyperpolarization-activated (inward rectifying) K + channels (6, 7) .
Levobupivacaine is the frequently preferred local anesthetic, which has previously been shown to be capable of blocking rat sciatic nerve conduction (8) . Its eff ects on nerve conduction and excitability parameters have been extensively studied, using traditional CNAP recording and TT methods, for the appropriate dose of perineural administration. TT is a relatively new method that provides information about the changes in ion channel activity; it enables on going assessment for clinical validation of several studies. Its main advantage over other methods is that it provides, non-invasively, a means for in vivo measurement of ion channel activity (6) . The aim of the present study was to investigate in detail the eff ects of levobupivacaine on nerve excitability in order to enlighten the changes in ionic channel activity. In addition, the conduction parameters acquired from the isolated nerve were evaluated for the conduction blockage eff ect of anesthetic agents by means of the traditional CNAP recording method.
EXPERIMENTAL

Animals
The experiments were carried out on 24 male adult Wistar albino rats, weighing 250-350 g, purchased from KONUDAM (N. E. University Experimental Medicine and Application Center, Konya, Turkey). All experimental procedures on animals were carried out in accordance with the ARRIVE guidelines and instructions of the Meram Medical Faculty Experimental Ethics Committ ee (N. E. University, Konya, Turkey). Aft er birth, rats were housed fi ve per cage at ambient temperature and humidity under a 12/12 h light/dark cycle. All animals received food and water ad libitum. Rats were maintained without any signs of neuro behavioral impairment throughout the experiments. Animals were separated into two groups, i.e., 8 rats for in vitro CNAP recordings from isolated sciatic nerves and 16 rats for in vivo multiple excitability measurements.
CNAP recording
In order to perform CNAP recording, right sciatic nerves of the fi rst group of rats were dissected at the hind paw aft er being sacrifi ced by cervical dislocation under deep anesthesia (intraperitoneal injection of 90 mg kg -1 ketamine and 10 mg kg -1 xylazine combination). Nerves were then rapidly transferred to the recording chamber super fused with modifi ed Krebs solution (composed of, in mmol L 20 , and glucose 10, pH 7.4, and gassed with a mixture of 95 % O 2 and 5 % CO 2 ) at a constant rate of 5 mL min -1 at constant temperature (37 ± 0.5 °C). Temperature was maintained using a heat jacket in the course of recording experiments. Stimuli were given with a stimulator (Model S88K, Grass Instruments Co., USA) at proximal ends of the nerve trunk via a stimulus isolation unit (Model SIU5, Grass Instruments Co.). Square-wave pulses of supramaximal intensity (100 μs duration and 1 Hz frequency) were used for nerve stimulation. CNAP recordings were performed via a suction electrode placed at the tibial branch of the isolated nerve trunk. Amplifi ed CNAP signals (Model CP511 AC amplifi er, Grass Instruments Co.) were digitized using an A/D converter card (Model PCL 1710, Advantech, Taiwan) at 40 KSPS (kilosamples s 
Multiple excitability measurements
Multiple excitability measurement tests were performed on 16 rats divided into two groups having equal numbers of animals (n = 8). Rats in the fi rst group, labeled LEV, were unilaterally administered a percutaneous injection of 0.5 mL of levobupivacaine (0.05 %, 1.7 mmol L -1 ) into the perineural space below the clear fascia covering the nerve itself, proximal to the bifurcation of the sciatic nerve. The second group (CON) served as a control and received 0.5 mL of saline (0.9 % NaCl), which served as a vehicle for levobupivacaine. Before perineural injection, rats were anaesthetized with an intraperitoneal injection of 90 mg kg -1 ketamine and 10 mg kg -1 xylazine combination to produce deep anesthesia. To maintain the level of anesthesia, supplementary doses were administered as required.
To conduct TT experimental protocols, thirty minutes aft er the perineural injection of levobupivacaine, the lower back regions of rats were shaved and placed prone on a heated table (MAY RTC9404-A Animal Rectal Temperature Controller, Commat Ltd., Turkey), which was controlled by a rectal thermistor probe to keep the body temperature at 37 °C. A stainless steel stimulating surface electrode pair was placed on the sciatic nerve, and Ag/ AgCl recording surface electrodes were positioned properly on the gastrocnemius muscle groups innervated by these nerves, very close to the point of perineural injection. The ring electrode serving as ground was att ached to the tail. Compound muscle action potentials (CMAPs) were amplifi ed and fi ltered (1 Hz to 3 kHz, Warner Instrument DP311 Amplifi er, USA) and line interference was removed using an online noise eliminator (HumBug 50/60 Hz Noise Eliminator, Digitimer Co., UK). The resultant signals were then digitized using a computer having an analog-digital converter at a sampling rate of 10 KSPS (National Instrument NI USB-6251 M series DAQ Device, USA). Stimulation was controlled by QTRACS soft ware connected to a data acquisition unit and a stimulator (DS5 type, Digitimer Co., UK). Fig. 1 illustrates the placement of stimulating and recording electrode pairs and the system used for the TT experiment.
In order to assess multiple excitability parameters, standard TT methods were applied (9) . Experimental procedure was performed using the soft ware in which multiple excitability protocol TRONDNF of QTRACS was implemented (H. Bostock, UCL Institute of Neurology, London, UK). Methodology and details of the equipment employed in this procedure were previously described elsewhere (6, (9) (10) (11) (12) . Briefl y, the fi rst step in our experiments was to obtain the CMAP of maximal amplitude by gradually increasing the stimulus strength by 2 %-steps. TRONDNF protocol mainly depends on the tracking of the current required to generate a target response of 40 % of maximal CMAP amplitude. The stimulus-response, strength-duration relationship, threshold electrotonus, current-threshold relationship and recovery cycle parameters were investigated during the multiple excitability testing procedure.
In the course of electrotonus, excitability was tested during and aft er polarizing currents of 100 ms duration, for both ±20 and ±40 % of the control threshold current. For the current (mA)-threshold (V) relationship, excitability was tested in the period following 200-ms lasting current pulses for the range of +50 to -100 % of the control threshold current by steps of 10 %. For the recovery cycle, excitability was tested for 18 intervals from 1.5 to 200 ms following a supramaximal conditioning stimulus.
Data analysis
CNAP recordings. -Calculations were conducted on the isolated nerve for two separate conduction velocity (m s -1 ) values, representing the fastest and the relatively slow conducting groups. The fi rst (CV init ) was derived using latency1 (Δt onset ), i.e., the time delay between the instant of stimulus delivery and the associated CNAP onset, while the second (CV peak ) was computed for latency 2 (Δt peak ), the time delay between the stimulus delivery instant and the associated CNAP reaching its maximum value. The distance of the traveling wave used in calculations was 30 mm. The amplitude of CNAPs (mV) and the areas under CNAPs (mV . ms) were also measured.
Multiple excitability tests. -Recordings obtained via the TRONDNF protocol were analyzed and plott ed using the QTRACP program, which performs an automated analysis of multiple excitability parameters. Analyses of excitability measurements were mainly done using data obtained from the stimulus-response relationship, strength-duration relationship, threshold electrotonus, current-threshold relationship and recovery cycle protocols, which are the sub-protocols of TRONDNF, as previously described elsewhere (8) .
Statistics. -Unless otherwise specifi ed, comparisons for time dependent eff ects of levobupivacaine were made using the one-way analysis of variance (ANOVA), followed by Duncan's post-hoc test for multiple comparisons where ANOVA yielded a signifi cant result. Student's t-test was used to determine whether levobupivacaine did or did not aff ect excitability parameters. Reliability of our results was tested using Cohen's d eff ect size calculation method and according to the obtained d results for all parameters, sample size was found to be suffi cient (13) . Statistical analyses were performed using the GraphPad Prism 5 soft ware, where p-values of < 0.05 were regarded as signifi cant. Data were presented as mean ± SEM throughout the text.
RESULTS AND DISCUSSION
CNAP parameters
The CNAP depression eff ect of levobupivacaine on isolated rat sciatic nerves is given in Fig. 2 . This sample CNAP recording demonstrates that levobupivacaine administration suppresses the CNAPs recorded from isolated nerves in a time-dependent manner, completely abolishing the CNAPs within 25 min. This eff ect was found to be reversible. Changes in the area under CNAP, CNAP amplitude, conduction velocities of the fastest (CV init ) and medium velocity (CV peak ) fi ber groups were computed using CNAP data at 5-min intervals aft er the administration (t = 0) of levobupivacaine (Fig. 3) .
Multiple excitability measurements
A representative CMAP recording from the gastrocnemius muscle (as in Fig. 1 ) demon strating the presence and absence of levobupivacaine is given in Fig. 4 . Excitability parameters of the rat sciatic nerve associated with CMAPs are summarized for CON and LEV groups in Table I . Comparison of the stimulus response relation ship of LEV and CON is given in Fig.  5a . A signifi cant increase, compared to CON, was found in stimulus current strength (in mA), yielding 50 % of maximal response (Fig. 5b ).
Curves associated with strength-duration properties of CON and LEV groups are given in Fig. 6a . According to Weiss's law, as the duration of a test stimulus is increased, current strength required to excite a single nerve fi ber or bundle decreases exponentially, eventually fl att ening out a symptotically for long stimulus durations to reach a value called rheobase (5) . The excitability parameters, strength-duration time constant (SDTC) and rheobase values derived from these curves are also given as a bar graph in Figs. 6b and 6c. SDTC and rheobase values of LEV, derived from these curves, were both found to be signifi cantly diff erent from those for CON (1.94 mA and 0.28 ms vs. 2.7 mA and 0.22 ms).
The threshold electroton us protocol aims to track the changes in excitability during and aft er the long-duration depolarization and hyperpolarization of sub-threshold current pulses. Threshold changes are plott ed as percent threshold reduction, so that depolarizing responses are plott ed upwards, which is more convenient for electrotonus. Mean threshold changes during and aft er the depolarization and hyperpolarization of sub-threshold current of 100 ms, corresponding to 40 and 20 % of maximal response (i.e., TEd 40 , TEd 20 and TEh 40 , TEh 20 , resp., for depolarizing and hyperpolarizing currents) for CON and LEV groups, are In the current threshold relationship, for an unconditioned test potential, the strength of the conditioning current is varied from +50 to -100 % of the threshold while keeping its duration constant. One can then obtain the curve for the current threshold relationship by delivering the test pulse of 1 ms duration at the end of polarizing current, corresponding to the rectifi cation due to K + channels' activation, i.e., the inward rectifi er. Current-threshold relationships for depolarization and hyperpolarization for CON and LEV groups were found to be similar (Fig. 7b) , without any signifi cant diff erence.
Recovery cycle (RC) properties, showing the relative refractory period, and providing information about super-excitability and late sub-excitability, are given in Fig. 8a for both CON and LEV. The RC curve for LEV was found to be shift ed to the right, meaning that the absolute refractory period for LEV had increased compared to CON (τ 0 in Fig. 8a ). The associated average relative refractory period values were found to increase signifi cantly for LEV (p < 0.05) compared to CON (Fig. 8b) .
In vitro conduction studies
In the experiments conducted in vitro, isolated rat sciatic nerves manifested a characteristic electrophysiological response to levobupivacaine (1.7 mmol L -1 ), i.e., a gradual CNAP depression with time. All responses to supramaximal stimuli were found to vanish within 25 min (Figs. 2 and 3) . Despite the fact that there is a very limited number of in vitro nerve conduction studies in the literature, this complete blocking eff ect of levobupivacaine is consistent with a recent study reporting that the maximum eff ect of levobupivacaine (0.5 mmol L -1 ) on the frog sciatic nerve CNAP amplitude occurred 20 minutes following exposure (14) . A similar response is reported in another study of motor and sensory functions in an in vivo behavioral method, however, for a relatively higher dose than we used (15) . Despite the diff erence in doses, considering the location and volume of injections, the impacts due to levobupivacaine could be considered to be the same.
The area of a CNAP waveform can be used as a measure of the number of activated nerve fi bers in the nerve trunk (16) . The signifi cant area decrease (~42 %) observed in the 5 th minute following drug administration (Fig. 3a) can be interpreted as the block of fi ber groups having diff erent conduction velocities, based on our previous studies (17) . Levobupivacaine was also found to cause a signifi cant decrease (~56 %) in CNAP amplitude in the 5 th minute (Fig. 3b) . Although the decrease is quite dramatic, amplitude change may not be a reliable measure of the duration of an anesthetic agent. Due to conduction velocity shift s between fi ber groups, there still seem to exist active fi bers conducting at a relatively lower velocity. It is known that the peak region of CNAP mainly consists of fi ber shaving a relatively lower conduction velocity (18) (19) (20) than the fastest group. While the fast fi bers, i.e., having a larger diameter and lower threshold, contribute to the initial segment of CNAP, the fi bers having are latively slower conduction velocity, i.e., having a smaller diameter and high threshold, contribute to the tail section of the CNAP waveform (21, 22) .
Conduction velocity changes calculated with respect to the on set (CV init ) and peak (CV peak ) instants of CNAP (Figs. 3c and 3d ) confi rmed that there should still exist a certain amount of fi bers conducting in the 5 th minute aft er levobupivacaine (0.05 %, 1.7 mmol L -1 ) administration. It is also apparent from Figs 3c and 3d that the signifi cant decrease of both CV init and CV peak starts in the 20 th minute. Therefore, the time points at which the dramatic decrease occurs may be considered as a reliable measure for the maximum eff ect of levobupivacaine. 
In vivo excitability studies
The time course of a drug eff ect is an important issue. In the conventional in vitro CNAP recording methods, there are two concerns that should be taken into account: the continuous action of levobupivacaine on the isolated nerve and the amount of impeding forces against diff usion. Therefore, we also tested the time point at which the maximal eff ect of levobupivacaine occurred by tracking the CMAP amplitude recorded from the gastrocnemius muscle. The CMAP results suggested the maximum eff ect to occur in the 25 th minute (data not shown), which is the same time point yielded by CNAP recordings. Therefore, this time point was chosen as the baseline for testing nerve excitability changes while applying the TT method.
Another fi nding from the TT method was the stimulus-response curve. As expected, it had a sigmoid shape for both CON and LEV groups (Fig. 5a) . Although the stimulating current strength (mA) for 50 % maximal response was signifi cantly diff erent for CON and LEV ( Fig. 5b and Table I , p < 0.05), the associated peak CMAP values (mV) were almost the same. This fi nding roughly refl ects the decrease in excitability due to LEV. However, a more detailed interpretation would be that levobupivacaine reduces the excitability of low-threshold fi bers, i.e., faster fi ber groups, due to the very fact that it is relatively harder to excite slower fi ber groups. Besides, it did not block conduction completely as it was the case of the isolated nerve.
Rheobase and chronaxie (SDTC) provide a conventional measure of nerve excitability and can be calculated using data from the CNAP recording method, which, however, requires multiple recordings. The TT method, on the other hand, makes it possible to determine them easily, as shown by several experimental and clinical studies (5) . The eff ects of levobupivacaine on rheobase and SDTC are given in Fig. 6 and Table I , where a negative correlation was found between the rheobase (Fig. 6c) and SDTC (Fig. 6b) . Rheobase and SDTC are nodal properties infl uenced by the nodal membrane excitability. Their dependence on the voltage level is consistent with persistent Na + channels' (Na p ) behavior. Na p channels are active near the threshold and their inactivation is not as rapid as that of transient Na + channels (6, 7, 23) . Depolarization decreases due to the Na + current through Na p , resulting in lower rheobase, whereas hyperpolarization has the opposite eff ect. As the charge-duration relationship suggests, SDTC takes values in the opposite direction from the rheobase (6) . Hence, the membrane is prevented from hyperpolarizing due to leakage of Na + through Na p channels, contributing to 3-5 % of the total Na + channel activity during the resting state of the membrane.
A decrease in membrane potential or a change in passive membrane properties would cause a decrease in SDTC values. Since levobupivacaine decreases Na + channels' permeability, the membrane should become hyperpolarized. This in turn leads to a decrease in SDTC, which is a strong evidence for a decrease in membrane excitability. This result suggests that proper functioning of persistent Na + channels in the rat sciatic nerve is restricted within 25 min aft er levobupivacaine injection, which may be responsible for decreased excitability.
Threshold electrotonus is another protocol enabling us to monitor the inter-nodal conductance, which in turn yields a characteristic patt ern of the change in excitability during and aft er long-term depolarizing and hyperpolarizing currents unable to trigger an action potential. Under such conditions, the strength of the test pulse required to obtain the predetermined target CMAP amplitude is also changed relative to the pulse onset. In our study, target amplitudes were chosen to yield 20 and 40 % of CMAP maximum amplitude. The rationale behind choosing two diff erent target response amplitudes is that the most excitable fi ber groups are the fastest ones and may result in 20 % target response, where the rest are the medium ones responsible for 40 % target response.
Threshold electrotonus curves revealed no diff erence for either TE d 40 or TEd 20 . The patt erns followed by the TEh 40 and TEh 20 curves for both CON and LEV were almost the same (Fig. 7a) . In the TEd 40 curve, excitability remained almost the same over the fi rst 20 ms, with a slight decrease up to 100 ms. TEd 20 curves of CON and LEV followed the same trend. These fi ndings are coherent with the TE (%) measures given in Table I . Since a change in nerve excitability during TEd is controlled successively by passive membrane properties (i.e., resistance and capacitance) and also via fast and slow K + channel conductance (5, 6), the threshold electrotonus fi ndings can be interpreted in such a way that levobupivacaine has no signifi cant eff ect on the passive membrane properties and on K + conductance for either fastest or medium velocity fi ber groups. Besides, the current-threshold curves for both groups were also found to follow the same trend (Fig. 7b) . These results support our suggestion of a limited eff ect of levobupivacaine on K + channels, since hyperpolarization deactivates inter-nodal K + channels while activating the inward rectifi er K + channels (5).
The sequence of change in excitability, following nerve fi ber depolarization, is called the recovery cycle, which can be either in an increasing (i.e., below baseline) or decreasing phase (i.e., above baseline). These phases are labeled in Fig. 8a as τ 0 , τ 1 , τ 2 , and τ 3 for the CON group. There was a complete rightward shift in the average curve of LEV groups, compared to CON groups, meaning that levobupivacaine infl uenced the inactivation and deactivation phases of ion channels. Increase in phase τ 0 (absolute refractory period) of the LEV group shows that even when the strongest stimuli are applied, the fi bers are absolutely unexcitable. This prolongation in τ 0 is due to the delay in inactivation of the transient voltage dependent Na + channels. In phase τ 1 (relative refractory period), axonal excitability in the LEV group is low, and there is also a signifi cant (p < 0.05) extension in duration (Fig. 8b ) that may be att ributed to the delay caused by levobupivacaine as it causes gradual recovery of transient Na + channels. Axonal excitability increases during phase τ 2 (supernormal period). Compared to the CON group, there is a substantial rightward shift in the LEV group, and its duration is longer. Finally, for phase τ 3 , the LEV group either vanishes completely or phase τ 2 (supernormal period) is delayed towards τ 3 as a result of complete shift .
CONCLUSIONS
The current study was designed to investigate, using two well-established methods, how the long-acting amide type local anesthetic levobupivacaine aff ects nerve conduction and excitability parameters.
Conventional methods based on the compound nerve action potential recording still keep their place in investigating the state of conduction and fi ber diameter distribution in peripheral nerve studies. As it was pointed out before, the time course of the eff ect of an administered anesthetic drug may be traced precisely by this method. The method also facilitates the estimation of conduction velocity shift s in fi ber groups and the excitability state of the nerve trunk. Various protocols of the TT method, however, make in vivo investigation of channel kinetics possible, even in humans.
Consequently, this study was aimed to investigate the electrophysiological parameters upon administration of levobupivacaine on isolated sciatic nerves for some time. This study employed an automated TT system to investigate multiple excitability parameters of the rat sciatic nerve, which corresponds to the maximum response following peri-neural injection of levobupivacaine.
Finally, the study has demonstrated that levobupivacaine (0.05 %, 1.7 mmol L -1 ) depresses conduction in the isolated sciatic nerve in a time-dependent manner, and that complete conduction block occurs 20 minutes aft er administration. Levobupivacaine causes a decrease in Na + channel activity (or permeability), with an increase in the rheobase and in absolute/relative refractory periods and a decrease of SDTC values, as revealed by the in vivo TT method results. Changes in the assessed parameters could be accepted asevidencefor the decrease in the excitability state of nerve fi bers in response to levobupivacaine application.
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